Ruian Gene: Zhejiang Great Health has reduced its shareholding to 10%.

Ruiang Gene announced that the information disclosure obligor, Zhejiang Big Health Industry Equity Investment Fund, will reduce its shareholding from 11.25% to 10% through centralized bidding reduction and passive dilution, due to the expiration of its operating period from January 10, 2023, to August 10, 2026. Before this change, it held 6,251,559 shares, and after the change, it will hold 5,585,464 shares. In addition, Zhejiang Big Health plans to continue reducing its holdings of no more than 1,675,675 shares, accounting for no more than 3% of the total share capital, from July 14 to October 13, 2026. As of the date of this report, this reduction plan has not yet been fully implemented.